PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript
PetMed Express Reports Q4 2026 Results: Full Earnings Call Transcript
PetMed Express Board Rejects Acquisition Proposals; Company To Remain Independent; Says Remains Open To Considering Any Inbound Indications Of Interest With Respect To Potential Deal That May Be Received In Future
PetMed Express: High-Risk Turnaround, Hidden Assets, Activism
PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
PetMed Express Announces Strategic Partnership With Rural King To Provide Pharmacy Infrastructure And E-Commerce Capabilities
PetMed: Fiscal Q2 Earnings Snapshot
PetMed: Fiscal Q1 Earnings Snapshot
Cardone Ventures Offers Full Buyout Of PetMed Express, Stock Soars
Cardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed Express
PetMed Express Shares Resume Trade
PetMed Express shares are trading higher after the company received an acquisition proposal from Cardone Ventures for approximately $89 million, or $4.25 per share.
PetMed Express Shares Halted On Circuit Breaker To The Upside, Stock Now Up 23.69%
PetMed Express Receives Proposal From Cardone Ventures To Acquire The Co For ~$89M, Or $4.25 Per Share
December 2025 Penny Stocks Worth Watching
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
PetMed Express shares are trading higher after the company announced it received an unsolicited and non-binding acquisition proposal from SilverCape Investments.
SilverCape Announced Non-Binding Proposal to Acquire 100% of PetMed Express' Outstanding Common Stock for $4.00/Share in Cash to Take Company Private -Amended 13D Filing
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.